Market Moves
Science Corp Raises $230 Million to Commercialise PRIMA Retinal Implant
Science Corporation closes a $230 million Series C with participation from Khosla Ventures, Lightspeed Venture Partners and Y Combinator, at a reported post-money valuation of $1.5 billion, as it targets a European launch of the PRIMA vision-restoration implant by mid-2026.